Increasing the selectivity of drug discrimination procedures

被引:34
作者
Appel, JB [1 ]
West, WB [1 ]
Rolandi, WG [1 ]
Alici, T [1 ]
Pechersky, K [1 ]
机构
[1] Univ S Carolina, Dept Psychol, Behav Pharmacol Lab, Columbia, SC 29208 USA
关键词
drug discrimination (DD); D-other; LSD (d-lysergic acid diethylamide); DMT; (t-methoxy-N; N-dimetyltryptamine); DOM(+/-)2,5 dimethoxy-4-methylamphetamine); lisuride; MDMA; (methylenedioxy-methamphetamine); quipazine; PCP; (phencyclidine); yohimbine;
D O I
10.1016/S0091-3057(99)00089-1
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
In an attempt to increase the selectivity of drug discrimination, rats were trained to discriminate LSD (0.08 mg/kg) from a group of "other" compounds consisting of cocaine (10 mg/kg), pentobarbital (5 mg/kg), and saline. Acquisition of this LSD-other discrimination was rapid (31 days) in chambers equipped with retractable levers and did not differ significantly from that of a group of animals trained to discriminate LSD from saline (26 days). In substitution (generalization) tests, hallucinogens such as LSD, DMT, and DOM mimicked LSD in a dose-dependent manner in both groups. The designer drug (+/-) MDMA substituted for LSD in the LSD-other group (ED50 = 1.38) but did not substitute for the training drug in the LSD-ND group; neither (+) MDMA nor PCP mimicked LSD in either group. Most importantly, lisuride, quipazine, and yohimbine, drugs that have been described as "false positives," substituted for LSD in animals trained to discriminate LSD from saline (ED(50)s = 0.012, 1.662, 2.344, respectively), but not in animals trained to discriminate LSD from other drugs. Thus, the LSD-other training procedure can be described as more selective than the standard drug-ND procedure. (C) 1999 Elsevier Science Inc.
引用
收藏
页码:353 / 358
页数:6
相关论文
共 19 条
[1]   DIFFERENTIATION BETWEEN THE STIMULUS EFFECTS OF (+)-LYSERGIC ACID DIETHYLAMIDE AND LISURIDE USING A 3-CHOICE, DRUG DISCRIMINATION PROCEDURE [J].
CALLAHAN, PM ;
APPEL, JB .
PSYCHOPHARMACOLOGY, 1990, 100 (01) :13-18
[2]  
ChojnackaWojcik E, 1997, POL J PHARMACOL, V49, P299
[3]   CROSS GENERALIZATION WITH LSD AND YOHIMBINE IN THE RAT [J].
COLPAERT, FC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 102 (3-4) :541-544
[4]  
COLPAERT FC, 1982, ARCH INT PHARMACOD T, V258, P283
[5]  
COLPAERT FC, 1986, PSYCHOPHARMACOLOGY, V90, P222
[6]   NEUROPHARMACOLOGICAL REASSESSMENT OF THE DISCRIMINATIVE STIMULUS PROPERTIES OF D-LYSERGIC-ACID DIETHYLAMIDE (LSD) [J].
CUNNINGHAM, KA ;
APPEL, JB .
PSYCHOPHARMACOLOGY, 1987, 91 (01) :67-73
[7]   Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors [J].
Egan, CT ;
Herrick-Davis, K ;
Miller, K ;
Glennon, RA ;
Teitler, M .
PSYCHOPHARMACOLOGY, 1998, 136 (04) :409-414
[8]   ROLE OF 5-HT2A AND 5-HT2C RECEPTORS IN THE STIMULUS EFFECTS OF HALLUCINOGENIC DRUGS .2. REASSESSMENT OF LSD FALSE POSITIVES [J].
FIORELLA, D ;
RABIN, RA ;
WINTER, JC .
PSYCHOPHARMACOLOGY, 1995, 121 (03) :357-363
[9]  
GLANTZ SA, 1992, PRIMER BIOSTATISTICS, P100
[10]  
GLENNON RA, 1991, NIDA RES MONOGR, V116